Literature DB >> 21508309

Biomarkers for Parkinson's disease.

Todd B Sherer1.   

Abstract

Biomarkers for detecting the early stages of Parkinson's disease (PD) could accelerate development of new treatments. Such biomarkers could be used to identify individuals at risk for developing PD, to improve early diagnosis, to track disease progression with precision, and to test the efficacy of new treatments. Although some progress has been made, there are many challenges associated with developing biomarkers for detecting PD in its earliest stages.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21508309     DOI： 10.1126/scitranslmed.3002488

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  16 in total

Review 1.  Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.

Authors:  Ying Zi; Zhongmin Yin; Weizhong Xiao; Xinwei Liu; Zhixiang Gao; Li Jiao; Lianfu Deng
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 2.  Chronotherapies for Parkinson's disease.

Authors:  Karim Fifel; Aleksandar Videnovic
Journal:  Prog Neurobiol       Date:  2019-01-15       Impact factor: 11.685

Review 3.  Unbiased approaches to biomarker discovery in neurodegenerative diseases.

Authors:  Alice S Chen-Plotkin
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

4.  Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.

Authors:  Christine R Swanson; Yosef Berlyand; Sharon X Xie; Roy N Alcalay; Lama M Chahine; Alice S Chen-Plotkin
Journal:  Mov Disord       Date:  2015-07-24       Impact factor: 10.338

Review 5.  The JAK/STAT signaling pathway: from bench to clinic.

Authors:  Xiaoyi Hu; Jing Li; Maorong Fu; Xia Zhao; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-11-26

Review 6.  The evolving role of diffusion magnetic resonance imaging in movement disorders.

Authors:  Christopher W Hess; Edward Ofori; Umer Akbar; Michael S Okun; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

7.  Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.

Authors:  Hongwei Qin; Jessica A Buckley; Xinru Li; Yudong Liu; Thomas H Fox; Gordon P Meares; Hao Yu; Zhaoqi Yan; Ashley S Harms; Yufeng Li; David G Standaert; Etty N Benveniste
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

8.  Analysis of clinical evaluation of response to treatment of Parkinson's disease with integrated Chinese and Western medicine therapy.

Authors:  Min Li; Ming-Hui Yang; Yi Liu; Xiao-Dong Luo; Jian-Zong Chen; Heng-Jun Shi
Journal:  Chin J Integr Med       Date:  2014-06-10       Impact factor: 1.978

Review 9.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

Review 10.  Epigenetic Regulation of Neuroinflammation in Parkinson's Disease.

Authors:  Madiha Rasheed; Junhan Liang; Chaolei Wang; Yulin Deng; Zixuan Chen
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.